FOXO TECHNOLOGIES INC.

FOXO Technologies Inc. (FOXO) is an insurtech company that applies epigenetic biomarkers and artificial intelligence to life insurance underwriting and product development. The company went public through a business combination with CF Acquisition Corp. VIII, a blank-check vehicle sponsored by Cantor Fitzgerald & Co. that completed its IPO in 2021. The merger closed in September 2022, and shares of the combined entity began trading on NYSE American under the FOXO ticker. The 10-Q filed in May 2022 covers an operating period prior to the closing of the business combination. For complete filing history, deal timelines, and SPAC analytics on FOXO Technologies, sign up for full access at SpacDesk.